PiVily / Connected PV Briefings

A complex PV topic.
A shared understanding.

Turn a complex pharmacovigilance topic into a shared understanding for your members, delegates, or professional cohort. Commission a source-led presentation, facilitated discussion, and concise takeaway.

Starting themes

Choose the question that matters.

The final topic and level of detail are agreed for each engagement.

From updates to connected intelligence

How do regulatory developments, functional perspectives, and professional judgment fit together?

Intended audience outcome

An understanding of the connections between information, assessment, ownership, and traceable action.

The global PV system, in perspective

How do global oversight, local practice, science, and governance relate to one another?

Intended audience outcome

A clearer picture of the PV ecosystem and the interfaces that different professionals encounter.

The multidimensional PV professional

Which capabilities help professionals contribute across scientific, technical, and organizational boundaries?

Intended audience outcome

A framework for discussing evidence, systems thinking, communication, and professional influence.

Who commissions a briefing?

Institutions with a professional audience.

Professional associations, academic and fellowship programmes, conferences, and cross-disciplinary professional communities.

Suitable audiences include PV and safety practitioners and colleagues in quality, regulatory, medical, evidence, and technology functions.

Format & commissioning

A defined scope before a confirmed engagement.

A starting format is a 45-minute virtual presentation and 15-minute discussion. Other formats, travel, recordings, and reuse rights are agreed separately.

Share your audience, central question, preferred timing, and intended outcome. PiVily will assess fit and propose deliverables, responsibilities, and fees. Selected pilots may be considered individually.

Briefings use public information and original materials. They provide independent professional insight; engagements do not include organization-specific regulatory advice or outsourced PV operations.

Start a briefing inquiry →
Dr. Osa Woghiren speaking at BioTechX USABioTechX USA · 2026

Your briefing lead

Dr. Osa Woghiren, PharmD

PiVily’s founder brings experience across global pharmacovigilance, QPPV oversight, international operations, regulatory intelligence, and governance.

Selected professional speaking topics include regulatory surveillance, real-world evidence and patient safety, global PV, and professional capability.

Explore her professional speaking record →Prior appearances document the founder’s experience. They do not indicate PiVily clients or institutional endorsements.

Before you inquire

Practical questions.

Can you work with an international audience?

Virtual engagements can accommodate audiences across regions, subject to availability and agreed timing. We define the relevant geography and source base during scoping. Local regulatory topics may require locally qualified contributors.

What does a briefing cost?

Fees are proposed after the topic, audience, preparation, delivery format, and reuse rights are understood. There is no commitment when you submit an inquiry. Selected pilot arrangements are considered individually.

Can the topic be adapted to our audience?

Yes. We agree the audience, intended understanding, and central question before confirming an engagement. The starting themes are a basis for discussion.

Can we record or reuse the materials?

Recording, redistribution, and reuse rights must be agreed before confirmation. They are scoped separately from attendance at the live session.

Start with your audience

What should they understand more clearly?

Discuss your brief →